Eden Research (LON:EDEN) Trading Down 13.2% – Here’s What Happened

Posted by Anthony Miller on Apr 2nd, 2025

Eden Research plc (LON:EDEN – Get Free Report) traded down 13.2% during mid-day trading on Monday . The company traded as low as GBX 2.26 ($0.03) and last traded at GBX 2.37 ($0.03). 1,775,147 shares traded hands during trading, an increase of 133% from the average session volume of 762,776 shares. The stock had previously closed at GBX 2.73 ($0.04).

Eden Research Price Performance

The company has a market capitalization of £14.35 million, a PE ratio of -9.42 and a beta of 0.92. The company has a quick ratio of 2.42, a current ratio of 3.80 and a debt-to-equity ratio of 1.26. The firm’s 50-day moving average is GBX 3.36 and its 200-day moving average is GBX 3.71.

Insider Transactions at Eden Research

In other Eden Research news, insider Lykele van der Broek purchased 256,000 shares of the stock in a transaction on Thursday, February 6th. The stock was acquired at an average cost of GBX 4 ($0.05) per share, with a total value of £10,240 ($13,238.53). Also, insider Sean M. Smith acquired 426,986 shares of Eden Research stock in a transaction dated Tuesday, April 1st. The shares were bought at an average cost of GBX 234 ($3.03) per share, for a total transaction of £999,147.24 ($1,291,722.35). In the last three months, insiders bought 1,391,473 shares of company stock worth $103,604,725. 14.02% of the stock is currently owned by corporate insiders.

Eden Research Company Profile

(Get Free Report)

Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.

Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites.